Literature DB >> 11711493

Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway.

I Gouni-Berthold1, C Seul, Y Ko, J Hescheler, A Sachinidis.   

Abstract

Gangliosides, sialic acid-containing glycophospholipids, accumulate in atherosclerotic vessels and appear to regulate the proliferation of various cell types. Furthermore, vascular smooth muscle cell (VSMC) proliferation is associated with the development and progression of cardiovascular diseases. To demonstrate whether gangliosides are able to modulate the VSMC growth, the effect of gangliosides GM1, GM2, and GM3 on cell DNA synthesis and cell number has been examined. Moreover, we investigated possible intracellular mechanisms by which GM1 and GM2 elicit their mitogenic effects. Stimulation of VSMCs with GM1 and GM2 resulted in a dose-dependent increase in DNA synthesis and cell number, whereas GM3 caused a decrease in DNA synthesis. GM1 and GM2 (50 micromol/L) stimulate phosphorylation of extracellular signal-regulated kinases (ERKs) 1 and 2 and phosphorylation of the c-Jun N-terminal kinase (JNK), with a maximum at 15 minutes, but they do not have an effect on the phosphorylation of p38 mitogen-activated protein kinase (MAPK). GM3 (50 micromol/L), on the other hand, does not stimulate any of the 3 aforementioned MAPKs. Pretreatment of the cells with 20 micromol/L PD 098,059 caused a complete inhibition of ERK1/2 and JNK MAPK, whereas pretreatment with a Ras (farnesyl transferase) inhibitor did not abrogate the GM1- and GM2-induced ERK1/2 phosphorylation. Furthermore, GM1 and GM2 did not activate Raf-1 kinase. Interestingly, pretreatment of VSMCs with 100 nmol/L pertussis toxin resulted in a complete inhibition of the ERK1/2 phosphorylation. Finally, the GM1- and GM2-induced increase in cell number was significantly inhibited by PD 098,059. We may conclude that GM1 and GM2 stimulate ERK1/2 via a pertussis toxin-sensitive G(i)-coupled receptor through a Raf-1 kinase-independent pathway. Moreover, the GM1- and GM2-induced VSMC growth is ERK1/2 dependent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711493     DOI: 10.1161/hy1101.093104

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway.

Authors:  Gudrun Ulrich-Merzenich; Heike Zeitler; Darius Panek; Dirk Bokemeyer; Hans Vetter
Journal:  Eur J Nutr       Date:  2007-03       Impact factor: 5.614

Review 2.  Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.

Authors:  Pallavi Asthana; Joaquim Si Long Vong; Gajendra Kumar; Raymond Chuen-Chung Chang; Gang Zhang; Kazim A Sheikh; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

3.  ERK Is a Critical Regulator of JC Polyomavirus Infection.

Authors:  Jeanne K DuShane; Michael P Wilczek; Colleen L Mayberry; Melissa S Maginnis
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Effects of amyloid β-peptides and gangliosides on mouse neural stem cells.

Authors:  Yutaka Itokazu; Midori Kato-Negishi; Yoshihiko Nakatani; Toshio Ariga; Robert K Yu
Journal:  Neurochem Res       Date:  2013-07-14       Impact factor: 3.996

5.  Role of nifedipine and hydrochlorothiazide in MAPK activation and vascular smooth muscle cell proliferation and apoptosis.

Authors:  J Wang; K Liu; H Wang; Z Li; Y Li; S Ping; A S A Bardeesi; Y Guo; Y Zhou; T Pei; L Deng; P Sheng; S Liu; C Li
Journal:  Herz       Date:  2016-11-09       Impact factor: 1.443

6.  Vesicular Ganglioside GM1 From Breast Tumor Cells Stimulated Epithelial-to-Mesenchymal Transition of Recipient MCF-10A Cells.

Authors:  Qilong Ma; Dinghao Zhuo; Feng Guan; Xiang Li; Xiaomin Yang; Zengqi Tan
Journal:  Front Oncol       Date:  2022-04-26       Impact factor: 5.738

7.  Ganglioside GM1 influences the proliferation rate of mouse induced pluripotent stem cells.

Authors:  Jae-Sung Ryu; Kyu-Tae Chang; Ju-Taek Lee; Malg-Um Lim; Hyun-Ki Min; Yoon-Ju Na; Su-Bin Lee; Gislain Moussavou; Sun-Uk Kim; Ji-Su Kim; Kinarm Ko; Kisung Ko; Kyung-A Hwang; Eun-Jeong Jeong; Jeong-Woong Lee; Young-Kug Choo
Journal:  BMB Rep       Date:  2012-12       Impact factor: 4.778

Review 8.  Vascular Diseases and Gangliosides.

Authors:  Norihiko Sasaki; Masashi Toyoda
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.